121 related articles for article (PubMed ID: 36940886)
1. Design of chondroitin sulphate coated proglycosomes for localized delivery of tofacitinib for the treatment of rheumatoid arthritis.
Gorantla S; Rao Puppala E; Naidu VGM; Saha RN; Singhvi G
Eur J Pharm Biopharm; 2023 May; 186():43-54. PubMed ID: 36940886
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid-coated proglycosomes for topical delivery of tofacitinib in rheumatoid arthritis condition: Formulation design, in vitro, ex vivo characterization, and in vivo efficacy studies.
Gorantla S; Puppala ER; Naidu VGM; Saha RN; Singhvi G
Int J Biol Macromol; 2023 Jan; 224():207-222. PubMed ID: 36273548
[TBL] [Abstract][Full Text] [Related]
3. Facile functionalization of Teriflunomide-loaded nanoliposomes with Chondroitin sulphate for the treatment of Rheumatoid arthritis.
Mahtab A; Rabbani SA; Neupane YR; Pandey S; Ahmad A; Khan MA; Gupta N; Madaan A; Jaggi M; Sandal N; Rawat H; Aqil M; Talegaonkar S
Carbohydr Polym; 2020 Dec; 250():116926. PubMed ID: 33049840
[TBL] [Abstract][Full Text] [Related]
4. Chondroitin Sulphate-Chitosan polyelectrolyte complexes for etorocoxib transdermal delivery:
Noshi SH; Ibrahim MS; Salama A; Fathy IA; Elsayyad NME
Pharm Dev Technol; 2023 Oct; 28(8):785-798. PubMed ID: 37610935
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid-coated solid lipid nanoparticles enhance antirheumatic activity and reduce toxicity of methotrexate.
Mirchandani Y; Patravale VB; Brijesh S
Nanomedicine (Lond); 2022 Jul; 17(16):1099-1114. PubMed ID: 36178114
[TBL] [Abstract][Full Text] [Related]
6. Coated nanostructured lipid carriers targeting the joints - An effective and safe approach for the oral management of rheumatoid arthritis.
Zewail M; Nafee N; Helmy MW; Boraie N
Int J Pharm; 2019 Aug; 567():118447. PubMed ID: 31226475
[TBL] [Abstract][Full Text] [Related]
7. Tofacitinib citrate-based liposomes for effective treatment of rheumatoid arthritis.
Shen Q; Shu H; Xu X; Shu G; Du Y; Ying X
Pharmazie; 2020 Apr; 75(4):131-135. PubMed ID: 32295688
[TBL] [Abstract][Full Text] [Related]
8. Modeling Combined Anti-Inflammatory Effects of Dexamethasone and Tofacitinib in Arthritic Rats.
Yu R; Song D; DuBois DC; Almon RR; Jusko WJ
AAPS J; 2019 Jul; 21(5):93. PubMed ID: 31342216
[TBL] [Abstract][Full Text] [Related]
9. Preclinical Explorative Assessment of Celecoxib-Based Biocompatible Lipidic Nanocarriers for the Management of CFA-Induced Rheumatoid Arthritis in Wistar Rats.
Nirbhavane P; Sharma G; Singh B; Khuller GK; Goni VG; Patil AB; Katare OP
AAPS PharmSciTech; 2018 Oct; 19(7):3187-3198. PubMed ID: 30143947
[TBL] [Abstract][Full Text] [Related]
10. Chitosan coated clove oil-based nanoemulsion: An attractive option for oral delivery of leflunomide in rheumatoid arthritis.
Zewail MB; El-Gizawy SA; Asaad GF; Shabana ME; El-Dakroury WA
Int J Pharm; 2023 Aug; 643():123224. PubMed ID: 37451327
[TBL] [Abstract][Full Text] [Related]
11. Transdermal delivery of fluvastatin sodium
El Menshawe SF; Nafady MM; Aboud HM; Kharshoum RM; Elkelawy AMMH; Hamad DS
Drug Deliv; 2019 Dec; 26(1):1140-1154. PubMed ID: 31736366
[TBL] [Abstract][Full Text] [Related]
12. pH and ROS Dual-Sensitive Nanocarriers for the Targeted Co-Delivery and On-Demand Sequential Release of Tofacitinib and Glucosamine for Synergistic Rheumatoid Arthritis Treatment.
Chen G; Deng S; Liu S; Zhao Y; Xiao Y; Zeng X; Xu Y; Cheng D; Chen B
Small; 2024 Jun; 20(24):e2308520. PubMed ID: 38169139
[TBL] [Abstract][Full Text] [Related]
13. M-134, a novel HDAC6-selective inhibitor, markedly improved arthritic severity in a rodent model of rheumatoid arthritis when combined with tofacitinib.
Bae D; Choi Y; Lee J; Ha N; Suh D; Baek J; Park J; Son W
Pharmacol Rep; 2021 Feb; 73(1):185-201. PubMed ID: 33188511
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Combined Ultrasound-and-Microbubbles-Mediated Diclofenac Gel Delivery to Enhance Transdermal Permeation in Adjuvant-Induced Rheumatoid Arthritis in the Rat.
Liao AH; Chung HY; Chen WS; Yeh MK
Ultrasound Med Biol; 2016 Aug; 42(8):1976-85. PubMed ID: 27181685
[TBL] [Abstract][Full Text] [Related]
15. Effects of chondroitin and glucosamine sulfate in a dietary bar formulation on inflammation, interleukin-1beta, matrix metalloprotease-9, and cartilage damage in arthritis.
Chou MM; Vergnolle N; McDougall JJ; Wallace JL; Marty S; Teskey V; Buret AG
Exp Biol Med (Maywood); 2005 Apr; 230(4):255-62. PubMed ID: 15792947
[TBL] [Abstract][Full Text] [Related]
16. In vivo evaluation of chondroitin sulfate-glycyl-prednisolone for anti-arthritic effectiveness and pharmacokinetic characteristics.
Onishi H; Isoda Y; Matsuyama M
Int J Pharm; 2013 Nov; 456(1):113-20. PubMed ID: 23954236
[TBL] [Abstract][Full Text] [Related]
17. Cardamonin (2',4'-dihydroxy-6'-methoxychalcone) isolated from Boesenbergia rotunda (L.) Mansf. inhibits CFA-induced rheumatoid arthritis in rats.
Voon FL; Sulaiman MR; Akhtar MN; Idris MF; Akira A; Perimal EK; Israf DA; Ming-Tatt L
Eur J Pharmacol; 2017 Jan; 794():127-134. PubMed ID: 27845065
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate Aspasomes Against Rheumatoid Arthritis: Optimized Hydrogel Loaded Liposomal Formulation with In Vivo Evaluation in Wistar Rats.
Ghosh S; Mukherjee B; Chaudhuri S; Roy T; Mukherjee A; Sengupta S
AAPS PharmSciTech; 2018 Apr; 19(3):1320-1336. PubMed ID: 29340978
[TBL] [Abstract][Full Text] [Related]
19. Ursolic acid rich Ocimum sanctum L leaf extract loaded nanostructured lipid carriers ameliorate adjuvant induced arthritis in rats by inhibition of COX-1, COX-2, TNF-α and IL-1: Pharmacological and docking studies.
Ahmad A; Abuzinadah MF; Alkreathy HM; Banaganapalli B; Mujeeb M
PLoS One; 2018; 13(3):e0193451. PubMed ID: 29558494
[TBL] [Abstract][Full Text] [Related]
20. Development and evaluation of tofacitinib transdermal system for the treatment of rheumatoid arthritis in rats.
Li Y; Sun Y; Wei S; Zhang L; Zong S
Drug Dev Ind Pharm; 2021 Jun; 47(6):878-886. PubMed ID: 33886401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
